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Research
AbstrAct
Objectives To examine associations between maternal 
pregnancy-specific stress and umbilical (UA PI) and 
middle cerebral artery pulsatility indices (MCA PI), 
cerebroplacental ratio, absent end diastolic flow (AEDF), 
birthweight, prematurity, neonatal intensive care unit 
admission and adverse obstetric outcomes in women 
with small for gestational age pregnancies. It was 
hypothesised that maternal pregnancy-specific stress 
would be associated with fetoplacental haemodynamics 
and neonatal outcomes.
Design This is a secondary analysis of data collected for a 
large-scale prospective observational study.
Setting This study was conducted in the seven major 
obstetric hospitals in Ireland and Northern Ireland.
Participants Participants included 331 women who 
participated in the Prospective Observational Trial 
to Optimise Paediatric Health in Intrauterine Growth 
Restriction. Women with singleton pregnancies between 
24 and 36 weeks gestation, estimated fetal weight <10th 
percentile and no major structural or chromosomal 
abnormalities were included.
Primary and secondary outcome measures Serial 
Doppler ultrasound examinations of the umbilical and 
middle cerebral arteries between 20 and 42 weeks 
gestation, Pregnancy Distress Questionnaire (PDQ) 
scores between 23 and 40 weeks gestation and neonatal 
outcomes.
Results Concerns about physical symptoms and body 
image at 35–40 weeks were associated with lower 
odds of abnormal UAPI (OR 0.826, 95% CI 0.696 to 
0.979, p=0.028). PDQ score (OR 1.073, 95% CI 1.012 to 
1.137, p=0.017), concerns about birth and the baby (OR 
1.143, 95% CI 1.037 to 1.260, p=0.007) and concerns 
about physical symptoms and body image (OR 1.283, 
95% CI 1.070 to 1.538, p=0.007) at 29–34 weeks were 
associated with higher odds of abnormal MCA PI. Concerns 
about birth and the baby at 29–34 weeks (OR 1.202, 
95% CI 1.018 to 1.421, p=0.030) were associated with 
higher odds of AEDF. Concerns about physical symptoms 
and body image at 35–40 weeks were associated with 
decreased odds of neonatal intensive care unit admission 
(OR 0.635, 95% CI 0.435 to 0.927, p=0.019).
Strengths and limitations of this study
 ► This study benefits from comprehensive, repeatedly 
collected stress and haemodynamic data, inclusion 
of cerebroplacental ratio and absent end diastolic 
flow analyses, and clinically useful dichotomisation 
of normal or abnormal haemodynamic outcomes.
 ► Moreover, this study benefits from the inclusion 
of neonatal outcomes, the provision of novel 
insights into specific stressors faced by women 
with complicated pregnancies and the inclusion of 
ethnicity and deprivation index scores as potential 
confounding variables.
 ► This study is limited by inconsistent sample sizes 
at each time point, unavailability of stress data for 
the full Prospective Observational Trial to Optimise 
Paediatric Health in Intrauterine Growth Restriction 
cohort, data collection primarily occurring late 
in pregnancy and a lack of a comparison group 
of women with appropriate for gestational age 
pregnancies.
 ► Moreover, this study is limited by the relatively low 
pregnancy-specific stress reported by the sample, 
which can make it difficult to detect clinically 
significant differences, and by the many statistical 
tests conducted, which increase the risk of type I 
error.
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Conclusions These findings suggest that fetoplacental haemodynamics 
may be a mechanistic link between maternal prenatal stress and fetal and 
neonatal well-being, but additional research is required.
InTroducTIon
Pregnancy-specific stress is characterised by concerns about 
fetal health, diet, physical symptoms, labour, mothering and 
relationship changes.1 2 Pregnancy-specific stress is a distinct 
clinical entity,3 and pregnancy-specific stress measures are 
more sensitive than general stress measures in predicting 
preterm birth,4 5 fetal behaviour6 and childhood devel-
opment.7–11 Although evidence links pregnancy-specific 
stress and fetal and infant outcomes, potential mechanistic 
pathways such as fetoplacental haemodynamics remain 
relatively unexplored. A recent systematic review reported 
12 studies of prenatal stress and haemodynamics in preg-
nancy as measured by Doppler ultrasound;12 only three 
measured pregnancy-specific stress.13–15 There is therefore 
an evidence gap regarding potential associations between 
pregnancy-specific stress and fetoplacental haemody-
namics.
Doppler ultrasound indirectly measures fetoplacental 
haemodynamics16 by insonating the umbilical artery (UA) 
and fetal middle cerebral artery (MCA).17 Poor placen-
tation results in increased resistance to blood flow in the 
UA,18 leading to a higher pulsatility index (PI), resistance 
index and systolic/diastolic ratio. Increased UA resistance 
is associated with intrauterine growth restriction (IUGR), 
fetal distress and adverse neurodevelopmental outcomes.19 
In more extreme cases, resistance to UA blood flow rises 
enough that blood flow is no longer observed during 
fetal cardiac diastole, at which point absent end diastolic 
flow (AEDF) is diagnosed. Increased fetal MCA blood 
flow can indicate fetal cardiovascular distress, hypoxia or 
anaemia, and an abnormally low MCA PI can indicate fetal 
‘brain-sparing’ due to severe hypoxia and acidosis.20 Fetal 
brain-sparing can also be indicated by an abnormal cere-
broplacental ratio (CPR), the ratio of MCA PI to UA PI, 
which may be a more sensitive predictor of adverse peri-
natal outcomes than either the UA or MCA PI alone.21–24
The Prospective Observational Trial to Optimise Paedi-
atric Health in Intrauterine Growth Restriction (PORTO) 
was conducted in 2010–2012 in the seven academic obstetric 
centres in Ireland and Northern Ireland. This study involved 
serial ultrasound assessments of 1116 women with small for 
gestational age (SGA) pregnancies25 and presents a unique 
opportunity to explore pregnancy-specific stress in relation 
to a broad range of Doppler ultrasound values.
The aim of this secondary analysis of PORTO data was 
to explore potential relationships among pregnancy-spe-
cific stress, fetoplacental haemodynamics and neonatal 
outcomes in women with SGA pregnancies. It was hypoth-
esised that higher pregnancy-specific stress would be 
associated with abnormal fetal circulation (UA PI, MCA 
PI, CPR and AEDF), prematurity, birth weight < 2500 g, 




The primary aims of PORTO were to evaluate multivessel 
Doppler changes in SGA fetuses (estimated fetal 
weight (EFW) < 10th percentile) and correlate them 
with paediatric morbidity. Eligibility criteria included 
singleton pregnancies 24+0–36+6 weeks gestation with 
EFW < 10th percentile for GA.26 Fetuses with major 
structural and/or chromosomal abnormalities were 
excluded. Institutional Review Board approval was 
obtained through each centre: the Rotunda Hospital 
Ethics Committee, the Belfast Health and Social Care 
Trust, the Coombe Women’s University Hospital Ethics 
Committee, Cork University Maternity Hospital Ethics 
Committee, University Hospital Galway Ethics Committee 
and the National Maternity Ethics Committee, and partic-
ipants gave written informed consent. PORTO recruited 
1200 consecutive ultrasound-dated singleton pregnan-
cies; 32 (3%) were excluded due to chromosomal and/
or structural abnormalities, 13 (1%) withdrew consent, 
13 (1%) delivered outside of Ireland and 26 (2%) were 
lost to follow-up, leaving a final sample of 1116 women. 
A recruitment flow chart can be found in figure 1. A 
sample size calculation for PORTO study indicated that 
depending on the baseline rates of outcomes considered, 
the study had sufficient power (80%) with a sample size of 
1100; all women who completed a Prenatal Distress Ques-
tionnaire (PDQ) at some point during their participation 
in PORTO were included in the analyses described here.
clinic visits
Referral for enrolment in PORTO occurred if there was 
clinical suspicion of SGA. A PORTO research sonogra-
pher confirmed EFW < 10th percentile and performed 
a detailed evaluation of fetal anatomy. Data collected 
included maternal and obstetric characteristics, delivery 
and birthweight outcomes, and perinatal morbidity and 
mortality. At enrolment, expectant mothers underwent 
health assessments that included blood pressure, height, 
weight, body mass index (BMI) and smoking and alcohol 
intake data collection. Parity and previous miscarriage 
were recorded; however, data about existing psychi-
atric illnesses, whether pregnancies were planned or 
unplanned or whether participants had a history of expo-
sure to domestic violence were not recorded for PORTO. 
Obstetric management, including fetal surveillance, was 
standardised across all seven centres. This consisted of 
fetal growth assessment and more frequent evaluation 
with UA Doppler, biophysical profile and/or cardioto-
cography. Decision to deliver was at the discretion of the 
individual consultant obstetrician and was generally based 
on abnormal cardiotocography findings. Antenatal corti-
costeroids were administered between 24+0–36+0 weeks 
gestation if delivery was thought to be likely within 1 week. 
Outcomes of infants admitted to NICU were recorded by 
neonatal medical or nursing staff; outcomes for infants 
not admitted to NICU were recorded by research sonog-
raphers.
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ultrasound examination
Ten research sonographers performed all Doppler 
evaluations. Prior to study commencement, structured 
training was provided by maternal-fetal medicine special-
ists, and quality assurance assessments were conducted 
at regular intervals. Surveillance included evaluation 
of amniotic fluid volume, biophysical profile scoring 
and multivessel Doppler of UA, MCA, ductus venosus, 
aortic isthmus and myocardial performance index at 
every subsequent contact with research sonographers. 
CPRs were also calculated for each fetus.27 In the event 
of AEDF, testing was increased at the discretion of the 
consultant obstetrician. All prenatal and ultrasound 
data were recorded on the ultrasound software system 
(Viewpoint; MDI Viewpoint, Jacksonville, Florida, USA) 
and uploaded onto a live, web-based, consolidated data-
base. All sonographic findings were recorded in patient 
case files and were available to managing clinicians. All 
Doppler data were interpreted using published, stan-
dardised references.28
Pregnancy-specific stress
The PDQ was introduced approximately halfway through 
PORTO in a staggered fashion to five of the seven partic-
ipating study centres: Coombe Women and Infants’ 
University Hospital, the National Maternity Hospital, the 
Rotunda Hospital, the Royal Jubilee Maternity Hospital in 
Belfast, Cork University Hospital and University Hospital 
Galway. University Hospital Limerick and Our Lady of 
Lourdes Hospital in Drogheda did not participate in this 
aspect of PORTO data collection. Women completed 
the 12-item PDQ by responding to each item on a five-
point Likert scale ranging from ‘not at all worried’ to 
‘extremely worried’. The PDQ provides an overall score 
and three factor scores.29 Factor 1 measures concerns 
about birth and the health of the baby, factor 2 measures 
concerns about physical symptoms and body image and 
factor 3 measures concerns about emotions and relation-
ships. PDQ scores were collected from women repeatedly 
across gestation, and scores were binned into three equal 
5-week intervals to allow for time-specific exploration of 
Figure 1 Prospective Observational Trial to Optimise Paediatric Health in Intrauterine Growth Restriction (PORTO) flow chart. 
EFW, estimated fetal weight; PDQ, Prenatal Distress Questionnaire.
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the associations between maternal pregnancy-specific 
stress and fetal and neonatal outcomes.
clinical outcome definitions
Vermont Oxford Network definitions30 were used to 
define adverse perinatal outcomes. Abnormal UA PI 
was defined as > 95th percentile,31 abnormal MCA PI 
as < 5th percentile32 and CPR < 1.08 was considered 
abnormal.33 Adverse perinatal outcome was defined as 
a binary composite outcome of any of the following 
outcomes: intraventricular haemorrhage, periventric-
ular leukomalacia, hypoxic ischaemic encephalopathy, 
necrotising enterocolitis, bronchopulmonary dysplasia, 
sepsis or death. Prematurity was defined as delivery 
before 37 weeks gestation.
deprivation index
The 2011 HP All-Island deprivation index uses three 
primary dimensions of disadvantage: demographic 
profile, social class composition and labour market situa-
tion, and provides 2011 Relative Index Scores that range 
from −40 (most disadvantaged) to 40 (most affluent) with 
a mean of 0 and an SD of 10.34
statistical analyses
Binary logistic regression analyses were performed to 
evaluate associations between pregnancy-specific stress, 
fetoplacental haemodynamics and neonatal outcomes. 
For each analysis, the p < 0.05 significance threshold was 
used. SPSS V.22 was used for data management and statis-
tical analyses. Because the literature suggests that maternal 
smoking,35–39 drinking,40 41 ethnicity,42–44 BMI,16 45 blood 
pressure,16 46 47 socioeconomic status48–53 and age43 45 can 
contribute to changes in fetoplacental haemodynamics 
or neonatal outcomes and parity can affect maternal 
psychological distress during pregnancy,54 these vari-
ables were included in the adjusted models. Although 
the literature also suggests that experience of previous 
miscarriage can affect maternal psychological distress 
during pregnancy,54–57 previous miscarriage and maternal 
pregnancy-specific stress were not associated at any time 
point in this sample, so miscarriage was not included in 
the statistical models. In order to reduce the number 
of variables used in the models, mean arterial pressure 
was calculated as 2/3(diastolic blood pressure)+1/3(sys-
tolic blood pressure). The NICU admission model was 
also adjusted for prematurity. PORTO participants with 
missing data relevant to these analyses were excluded 
from the original database.
resulTs
Participants
Of 376 recruited women who completed at least one 
PDQ over the course of the PORTO study, 45 (12%) 
were excluded: 2(0.5%) delivered outside of Ireland, 
4 (1%) were recruited outside of the 24+0–36+6 GA 
recruitment window, 6 (2%) did not meet the EFW 
< 10th percentile inclusion criterion, 12 (3%) had 
pregnancies with congenital anomalies and 21 (6%) 
had incomplete data collection. This resulted in a total 
of 331 women completing the full study protocol; a 
recruitment flow chart is presented in figure 1. A total 
of 82 women completed at least one PDQ within the 
first time point bin, 205 women completed at least one 
PDQ within the second time point bin and 213 women 
completed at least one PDQ within the third time point 
bin; 42 women completed at least one PDQ within all 
three time point bins. The mean maternal age was 29.9 
years, and 86.1% of mothers were of Western European 
origin. The mean GA at enrolment was 29.6 weeks, 
and the mean GA at delivery was 38.2 weeks. Maternal 
demographics and fetal characteristics are summarised 
in table 1. Women in these analyses differed from the 
total PORTO cohort in several ways: women in these 
analyses were enrolled in PORTO study earlier in their 
pregnancies (p=0.003), had higher systolic blood pres-
sure (p=0.048), were more likely to be of European 
extraction (p=0.044), were less likely to have pre-ec-
lampsia (p=0.035) and gave birth later (p=0.016) to 
babies with higher birthweights (p=0.014). Moreover, 
women in these analyses were less likely to have their 
infant admitted to the NICU (p=0.023) and had babies 
with significantly higher 5 min Apgar scores (p=0.001). 
Demographic and clinical characteristics of the 
current sample can be found in table 1, and compari-
sons between women in the overall PORTO cohort and 
those in these analyses can be found in online supple-
mentary table 1.
Pregnancy-specific stress in this sample
Participants reported surprisingly low levels of pregnan-
cy-specific stress considering that they were informed 
that their pregnancies were high risk. Mean PDQ scores 
in this sample ranged from 11.0 (SD 6.64) at 35–40 
weeks to 12.7 (SD 8.07) at 23–28 weeks (table 2). As 
described in table 3, women with AEDF diagnoses 
reported more concerns about eating healthy foods 
and a balanced diet for the baby (p=0.023) and having 
a healthy baby (p=0.013), and more fear about the 
possibility of premature delivery (p<0.001) than women 
without AEDF diagnoses. Interestingly, there were no 
item-level differences between women with normal or 
abnormal UA PI.
Pregnancy-specific stress and fetoplacental haemodynamics
The following sections outline associations found before 
and after adjustment between maternal pregnancy-spe-
cific stress and abnormal UA PI, MCA PI, absent end 
diastolic flow and abnormal CPR.
Umbilical artery
There were no significant associations between PDQ 
scores or factor scores and abnormal UA PI at any time 
point before adjustment for confounders. After adjust-
ment, concerns about physical symptoms and body image 
at 35–40 weeks were significantly associated with lower 
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odds of abnormal UA PI (OR 0.826, 95% CI 0.696 to 
0.979, p=0.028).
Middle cerebral artery
Before adjustment, PDQ score (OR 1.058, 95% CI 1.007 
to 1.111, p=0.026), concerns about birth and the health 
of the baby (OR 1.100, 95% CI 1.018 to 1.188, p=0.015) 
and concerns about physical symptoms and body image 
(OR 1.219, 95% CI 1.040 to 1.428, p=0.015) at 29–34 
weeks were significantly associated with increased odds 
of abnormal MCA PI. After adjustment, PDQ score 
(OR 1.073, 95% CI 1.012 to 1.137, p=0.017), concerns 
about birth and the baby (OR 1.143, 95% CI 1.037 to 
1.260, p=0.007) and concerns about physical symptoms 
and body image (OR 1.283, 95% CI 1.070 to 1.538, 
p=0.007) at 29–34 weeks were significantly associated with 
higher odds of abnormal MCA PI.
absent end diastolic flow
Before adjustment, PDQ score (OR 1.082, 95% CI 1.005 
to 1.166, p=0.037) and concerns about birth and the 
health of the baby (OR 1.216, 95% CI 1.074 to 1.376, 
p=0.002) at 29–34 weeks were significantly associated with 
increased odds of AEDF. After adjustment, only concerns 
about birth and the health of the baby at 29–34 weeks 
(OR 1.202, 95% CI 1.018 to 1.421, p=0.030) were signifi-
cantly associated with higher odds of AEDF.
cerebroplacental ratio
There were no significant associations between PDQ or 
factor scores and CPR <1.08 before or after adjustment. 
The results of the unadjusted and adjusted binary logistic 
regression models for pregnancy-specific stress in relation 
to abnormal fetoplacental haemodynamics are shown 
in online supplementary table 2. Figure 2 depicts the 
abnormal UA PI and MCA PI analyses.
Pregnancy-specific stress and neonatal outcomes
The following sections outline associations found before 
and after adjustment between maternal pregnancy-spe-
cific stress and prematurity, NICU admission, birth weight 
< 2500 g and composite adverse perinatal outcome.
Prematurity
Concerns about birth and the health of the baby at 29–34 
weeks were significantly associated with greater odds of 
prematurity before adjustment (OR 1.084, 95% CI 1.008 
to 1.166, p=0.031), but this association was no longer 
present following adjustment.
Table 2 Pregnancy-specific stress in this sample
Pregnancy Distress Questionnaire 
score n Mean SD
23–28 weeks 80 12.70 8.07
  Birth and the health of the baby 81 7.69 4.79
  Physical symptoms and body image 82 2.97 2.41
  Relationships and emotions 80 2.02 2.19
29–34 weeks 197 12.07 7.11
  Birth and the health of the baby 203 7.45 4.40
  Physical symptoms and body image 205 2.72 2.19
  Relationships and emotions 203 1.84 1.98
35–40 weeks 213 11.26 6.56
  Birth and the health of the baby 197 6.75 4.35
  Physical symptoms and body image 203 2.54 2.06
  Relationships and emotions 204 1.65 1.85
Table 1 Characteristics of participants
Characteristics (n=331)
Maternal characteristics
  Deprivation index score  1.07±12.50
  Height (cm) 162.41±6.41
  Weight (kg) 64.15±13.3
  BMI 24.29±4.67
  Age (years) 29.88±5.65
  GA at enrolment in PORTO (weeks) 29.56±4.01
  Diastolic blood pressure 67.53±9.55
  Systolic blood pressure 114.54±14.59
  European ethnicity 285 (86.1)
  Spontaneous conception 329 (99.4)
  Smoker 76 (23.0)
  Drinker 6 (1.8)
  Pre-eclampsia 21 (6.3)
Infant characteristics
  Birth weight (g) 2573.88±658.69
  GA at delivery (weeks) 38.16±2.73
  Preterm (<37 weeks) 68 (20.5)
   Late/moderately (32 to <37 weeks) 51 (15.4)
   Very (28 to <32 weeks) 15 (4.5)
   Extremely (<28 weeks) 2 (0.6)
  Admitted to NICU 77 (23.3)
  Adverse perinatal outcome 11 (3.3)
  Apgar score at 1 min 8.58±1.06
  Apgar score at 5 min 9.58±0.60
  Abnormal UA PI (IUGR) 122 (36.9)
  AEDF 20 (6.0)
  GA at AEDF diagnosis 29.45±3.68
  Abnormal MCA PI 114 (34.4)
  Abnormal CPR 57 (17.2)
Continuous variables represented as mean±SD and categorical 
variables as n (%).
AEDF, absent end diastolic flow; BMI, body mass index; 
CPR, cerebroplacental ratio; GA, gestational age; 
IUGR, intrauterine growth restriction; MCA, middle cerebral artery; 
NICU, neonatal intensive care unit; PI, pulsatility index; PORTO, 
Prospective Observational Trial to Optimise Paediatric Health 
in Intrauterine Growth Restriction; UA, umbilical artery.
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nIcu admission
Before adjustment, concerns about birth and the health 
of the baby at 29–34 weeks (OR 1.096, 95% CI 1.023 to 
1.175, p=0.009) were associated with increased odds of 
NICU admission, while concerns about physical symp-
toms and body image at 35–40 weeks (OR 0.724, 95% CI 
0.541 to 0.969, p=0.030) were associated with decreased 
odds of NICU admission. After statistical adjustment, 
concerns about physical symptoms and body image at 
35–40 weeks remained associated with decreased odds 
of NICU admission (OR 0.635, 95% CI 0.435 to 0.927, 
p=0.019).
Birthweight < 2500 g
Concerns about birth and the health of the baby at 29–34 
weeks were associated with greater odds of birthweight < 
Table 3 Differences in Pregnancy Distress Questionnaire (PDQ) items between women with normal and abnormal umbilical 
artery pulsatility index (UA PI) and absence or presence of absent end diastolic flow (AEDF)
PDQ item








  Mean (SD) Mean (SD)
1. I find weight gain during pregnancy 
troubling
0.78 (0.88) 0.73 (0.96) 0.632 0.77 (0.92) 0.58 (0.75) 0.375
2. Physical symptoms of pregnancy such as 
nausea, vomiting, swollen feet or backaches 
irritate me
1.36 (1.03) 1.14 (0.94) 0.053 1.27 (0.99) 1.39 (1.18) 0.622
3. I am worried about handling the baby when 
I first come home from the hospital
0.74 (0.91) 0.80 (1.01) 0.590 0.74 (0.93) 1.03 (1.17) 0.201
4. Emotional ups and downs during pregnancy 
annoy me
1.07 (1.00) 1.04 (0.96) 0.768 1.04 (0.97) 1.35 (1.15) 0.170
5. I am troubled that my relationships with 
other people important to me are changing 
due to my pregnancy
0.43 (0.75) 0.35 (0.58) 0.279 0.41 (0.70) 0.22 (0.45) 0.263
6. I am worried about eating healthy foods and 
a balanced diet for the baby
1.11 (1.01) 1.20 (1.16) 0.481 1.11 (1.06) 1.67 (1.10) 0.023
7. Overall, the changes in my body shape and 
size during pregnancy bother me
0.64 (0.81) 0.49 (0.72) 0.078 0.58 (0.78) 0.53 (0.73) 0.742
8. I am concerned that having a new baby will 
alter my relationship with the baby’s father
0.42 (0.80) 0.32 (0.63) 0.218 0.40 (0.75) 0.18 (0.49) 0.073
9. I worry about having an unhealthy baby 1.85 (1.17) 1.96 (1.26) 0.440 1.85 (1.19) 2.54 (1.28) 0.013
10. I am anxious about labour and delivery 1.89 (1.13) 1.73 (1.10) 0.204 1.84 (1.11) 1.58 (1.25) 0.299
11. The possibility of premature delivery 
frightens me
1.62 (1.18) 1.65 (1.23) 0.833 1.57 (1.15) 2.53 (1.44) <0.001
12. I am worried that I might not become 
emotionally attached to the baby
0.40 (0.78) 0.32 (0.59) 0.355 0.36 (0.72) 0.50 (0.66) 0.406
Figure 2 Abnormal umbilical artery pulsatility index (UA PI) and middle cerebral artery (MCA) PI as predicted by pregnancy-
specific stress. ORs >1.0 represent increased odds of the outcome occurring, while ORs <1.0 indicate decreased odds of 
the outcome occurring. Points represent ORs and brackets represent 95% CIs. Unadjusted models are represented in black. 
Adjusted models (grey) include maternal smoking, drinking, Western European origin, body mass index, mean arterial pressure, 
deprivation index score, parity and age at enrolment in the Prospective Observational Trial to Optimise Paediatric Health 
in Intrauterine Growth Restriction. PDQ, Pregnancy Distress Questionnaire.
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2500 g before (OR 1.080, 95% CI 1.012 to 1.153, p=0.020) 
but not after adjustment.
adverse perinatal outcome
There were no significant associations between preg-
nancy-specific stress and adverse perinatal outcome. 
The results of the unadjusted and adjusted binary 
logistic regression models for pregnancy-specific stress 
in relation to birthweight and NICU admission are 
provided in figure 3, and the unadjusted and adjusted 
analyses regarding neonatal outcomes are provided in 
online supplementary table 3.
dIscussIon
Pregnancy-specific stress was associated in this sample 
with increased odds of AEDF and abnormal MCA PI, and 
decreased odds of abnormal UA PI and NICU admis-
sion. However, these associations were small and varied 
according to the timing and nature of stress reported. 
Only three studies have explored associations between 
pregnancy-specific stress and Doppler ultrasound param-
eters, and this is the first exploration of associations 
between pregnancy-specific stress and MCA PI, CPR and 
AEDF in women with SGA pregnancies.
The association between concerns about physical symp-
toms and body image at 35–40 weeks and decreased odds 
of NICU admission is surprising. Women with higher 
concerns about physical symptoms and body image may 
be more conscious about nutrition and physical activity; 
however, this cannot be explored further as nutrition and 
exercise data were not collected for PORTO. It may be 
of interest in future studies to collect nutrition, physical 
activity and health-related behavioural data.
Associations between pregnancy-specific stress and 
both decreased odds of abnormal UA PI and increased 
odds of AEDF may appear contradictory. It is possible 
that women with healthier pregnancies, who may there-
fore be experiencing lower concerns about birth and the 
health of the baby, might instead have more concerns 
about physical symptoms and body image, which were 
associated with lower odds of abnormal UA PI. More-
over, women with AEDF were informed of their further 
increased medical risk, admitted as inpatients, and 
provided with a premature delivery plan, and therefore 
represent a unique population within this study. In order 
to determine whether there were associations between 
pregnancy-specific stress and subsequent AEDF, it would 
have been necessary to collect baseline PDQ data before 
diagnosis. AEDF diagnosis may also have increased preg-
nancy-specific stress; women with AEDF had higher mean 
PDQ scores and reported more concerns about eating 
health foods and a balanced diet for the baby, having an 
unhealthy baby and the prospect of premature delivery 
than women without AEDF (table 3). It is also possible 
that greater concerns about birth and the health of the 
baby may result in reduced concerns about other aspects 
of pregnancy. Increased monitoring or participation in 
PORTO may also have partially but not entirely amelio-
rated stress associated with AEDF diagnosis. Women with 
AEDF may represent a particularly vulnerable population 
that would benefit from additional support. It would be 
useful in future studies to include comparison groups of 
women with low-risk pregnancies to determine whether 
regular monitoring or study participation ameliorates 
pregnancy-specific stress, and whether this differs by 
medical risk severity.
Maternal pregnancy-specific stress may also trigger 
an inflammatory state characterised by increased nitric 
oxide (NO) and corticotrophin-releasing hormone 
(CRH), which may result in decreased resistance to blood 
flow in the UA. Research suggests that stress triggers an 
NO upregulation, chronic stress is associated with vaso-
dilation, NO inhibition increases umbilical-placental 
vasoconstriction and decreases umbilical blood flow, and 
abnormal UA Doppler waveforms are associated with 
lower NO activity.58–63 Similarly, CRH, a peptide hormone 
that plays an important role in stress, is also found in 
human placentas,64 is partly mediated by NO65 and is 
Figure 3 Birthweight < 2500 g and NICU admission as predicted by pregnancy-specific stress. ORs >1.0 represent increased 
odds of the outcome occurring, while ORs <1.0 indicate decreased odds of the outcome occurring. Points represent ORs 
and brackets represent 95% CIs. Unadjusted models are represented in black. Adjusted models (grey) include maternal 
smoking, drinking, Western European origin, body mass index, mean arterial pressure, deprivation index score, parity and age 
at enrolment in the Prospective Observational Trial to Optimise Paediatric Health in Intrauterine Growth Restriction. Adjusted 
neonatal intensive care unit (NICU) admission models also include adjustment for prematurity. PDQ, Pregnancy Distress 
Questionnaire. 
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one of the most potent fetal vasodilators.66 There may 
be an adaptive placental mechanism in which increased 
CRH release to the fetus is triggered by fetal hypoxia or 
acidosis.67–69
Due to insufficient studies that comprehensively measure 
biopsychosocial factors in relation to haemodynamics in 
pregnancy, it is only possible to theorise about reasons for 
associations between pregnancy-specific stress and fetopla-
cental haemodynamics. Because pregnancy-specific stress 
was not measured in the current study prior to recruit-
ment to a study about higher-risk pregnancy, and women 
in PORTO were not blinded to their Doppler results, it is 
not possible in the current analyses to determine whether 
increases in pregnancy-specific stress caused the haemody-
namic changes or adverse neonatal outcomes observed. 
Future studies would benefit from measuring maternal 
mental health variables prior to the first Doppler ultra-
sound assessment. There is also a need for additional 
research examining potential associations among psycho-
social data, haemodynamics and biomarkers. Future 
studies would also benefit from a more multidimensional 
approach to prenatal stress,70–72 measuring racism expo-
sure,4 73–75 chronic stress, major life events,76 health-related 
behaviours,71 domestic violence exposure,77–79 resilience80 
and partner/social support.76 80–82 Such studies would 
contribute to a more nuanced, biopsychosocial model of 
obstetric research. Moreover, future studies assessing associ-
ations between maternal mental health and fetal and infant 
well-being in the context of SGA or growth-restricted preg-
nancy would benefit from including fetal biometry, uterine 
artery Doppler velocimetry and analysis of placental histo-
morphology.
This study has several limitations. Inconsistent sample 
sizes at each time point limit immediate clinical utility, 
result in varying statistical power and prevent analyses for 
all outcomes at all time points. Because the PDQ was not 
introduced until approximately halfway through PORTO 
and was not collected in all centres, stress data were not 
available for the full PORTO cohort and many women 
did not have stress data collected until late in pregnancy. 
This may have resulted in selection bias and does not 
permit generalisation of these findings to other stages 
of pregnancy. Differences in key clinical characteristics, 
including pre-eclampsia, GA at delivery, birthweight, 
Apgar scores at 5 min and NICU admission, suggest that 
women included in these analyses may have been expe-
riencing somewhat healthier pregnancies than the rest 
of the PORTO cohort. Relatively low pregnancy-spe-
cific stress reported also limits detection of associations 
between maternal stress and fetal or neonatal outcomes. 
Women with appropriate for GA pregnancies were also 
not included in PORTO; these findings may therefore 
not be generalisable to the general obstetric popula-
tion. Medication use, illicit substance use, psychiatric 
diagnoses, domestic violence exposure and whether 
pregnancies were planned or unplanned were also not 
recorded. Only three studies linking prenatal stress and 
haemodynamics in pregnancy excluded women taking 
psychiatric medication;15 83 84 this is a limitation in the 
evidence on this topic.85 Likewise, although unplanned 
pregnancy has been associated with maternal depression 
and anxiety86–88 and intimate partner violence during 
pregnancy has been associated with an increased risk of 
low birthweight and prematurity,89 90 these factors are 
rarely considered in similar studies.
Importantly, conducting many statistical tests increases 
the likelihood that significant findings may be false 
positives. However, the Bonferroni correction was deter-
mined to be overly conservative for these analyses for 
two reasons. First, pregnancy-specific stress was highly 
correlated across gestation and the tests were therefore 
highly dependent, which was confirmed in this sample 
using Pearson’s correlations among the three binned PDQ 
scores. Second, this is the first repeated, time-sensitive 
analysis of associations between pregnancy-specific stress 
and fetoplacental haemodynamics or neonatal outcomes, 
and in the interest of avoiding type II errors, multiple 
comparison corrections were not performed. The results 
presented here should therefore be considered potential 
targets for future research rather than conclusive indi-
cations of the time-specific impact of pregnancy-specific 
stress on fetal well-being or neonatal outcomes.
This study also has several strengths. Comprehensive, 
repeatedly collected stress and haemodynamic data were 
available for a relatively large sample of women, CPRs 
could be calculated and there were sufficient women with 
AEDF to allow analysis for most time points. Although 
analysing stress at three time points reduces statistical 
power, it allows for time-specific insights into the effects 
of pregnancy-specific stress on Doppler ultrasound 
parameters and neonatal outcomes currently lacking in 
available studies. The overall sample size and sample sizes 
at each time point in the current study are also relatively 
large within the context of the available literature on 
prenatal stress and fetoplacental Doppler velocimetry.12 
Moreover, because this was an SGA sample, it was possible 
to examine associations between maternal stress and 
abnormal Doppler findings, while most studies to date 
have reported statistically but not clinically significant 
associations with continuous outcomes. None of the 12 
studies reporting associations between prenatal stress and 
Doppler ultrasound also reported neonatal outcomes.12 
Factor scores also permit novel insights about stressors 
faced by women with complicated pregnancies. This study 
further benefited from including ethnicity and depri-
vation index scores as potential confounding variables. 
Despite evidence linking socioeconomic status and preg-
nancy complications,48–53 few of the 12 previous studies 
adjusted for socioeconomic factors.
In summary, this study presents findings that preg-
nancy-specific stress was associated with increased odds 
of AEDF and abnormal MCA PI and reduced odds of 
abnormal UA PI and NICU admission in 331 women 
with SGA pregnancies. This study represents a valuable 
addition to research into associations between maternal 
prenatal stress and fetal and neonatal outcomes due to its 
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relatively large sample sizes, comprehensive data collec-
tion, repeated design, clinically useful dichotomisation of 
normal/abnormal blood flow and analysis of both overall 
stress and three specific stressors. These findings suggest 
that pregnancy-specific stress can be associated with 
fetoplacental haemodynamics and neonatal outcomes 
in women with SGA pregnancies, and merits further 
research attention.
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